Evidence map›Paper›PMID 35734853›Full record

ArticlePrenatal diagnosis2022

Views of patients and parents of children with genetic disorders on population-based expanded carrier screening.

Anke J Woudstra, Lieke M van den Heuvel, Elsbeth H van Vliet-Lachotzki, Wybo Dondorp, Phillis Lakeman, Lotte Haverman, Irene M van Langen, Lidewij Henneman

Abstract read
In one paragraph

Article in Prenatal diagnosis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anke J WoudstraDepartment of Human Genetics, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Lieke M van den HeuvelDepartment of Human Genetics, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Elsbeth H van Vliet-LachotzkiDutch Patient Alliance for Rare and Genetic Diseases (VSOP), Soest, The Netherlands.
Wybo DondorpDepartment of Health, Ethics & Society, Maastricht University, Research Schools CAPHRI and GROW, Maastricht, The Netherlands.ORCID 0000-0003-4052-7192
Phillis LakemanAmsterdam Reproduction and Development Research Institute, Amsterdam, The Netherlands.ORCID 0000-0001-6385-1804
Lotte HavermanAmsterdam Reproduction and Development Research Institute, Amsterdam, The Netherlands.ORCID 0000-0001-7849-0562
Irene M van LangenDepartment of Clinical Genetics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-0960-7154
Lidewij HennemanDepartment of Human Genetics, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0003-3531-0597

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveFaster and cheaper next generation sequencing technologies have enabled expansion of carrier screening for recessive disorders, potentially facilitating population-based implementation regardless of ancestry or family history. Little is known, however, about the attitudes regarding population-based carrier screening among families with genetic disorders. This study assessed views among parents and patients with a recessive disorder and parents of children with Down syndrome (DS) on expanded carrier screening (ECS).

methodIn total, 85 patients with various recessive disorders, 110 parents of a child with a recessive disorder and 89 parents of a child with DS participated in an online survey in the Netherlands. Severity of recessive disorders was classified as mild/moderate or severe/profound.

resultsThe majority of the (parents of) patients with a recessive disorder had a positive attitude towards population-based ECS, including screening for their own or their child's disorder. DS parents were significantly less positive towards ECS. Subgroup analyses showed that the severity of the disorder, rather than being a patient or parent, influences the attitudes, beliefs and intention to participate in ECS.

conclusionOur findings have important implications for future implementation initiatives as they demonstrate the different perspectives from people with experiential knowledge with genetic disorders.

Indexed as

Mass ScreeningParentsChildFamilyGenetic Carrier ScreeningHumansSurveys and Questionnaires

Identifiers

PMID35734853
PMCPMC9543353

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.